India approved two COVID-19 vaccines for Emergency Use

The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved by DGCI for emergency use? COVAXIN and COVISHIELD What is COVAXIN? The COVAXIN is the COVID-19 vaccine developed by Bharat Biotech and ICMR (Indian council of Medical ..

Month: Current Affairs - January, 2021

Category: Science & Technology Current Affairs

Topics: Bharat Biotech • COVAXIN • Covishield • DGCI • Emergency Use Authorisation • HGCO19 • ICMR • SPUTNIK V • ZyCov-D

COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India

On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to be held in partnership with the Indian Council of Medical Research. The trials are the largest clinical trials that is conducted for COVID-19 vaccine in the country. ..

Month: Current Affairs - November, 2020

Category: India Nation & States Current Affairs

Topics: Bharat Biotech • COVAXIN • COVAXIN Vaccine • ICMR • Moderna • National Institute of Virology • Pfizer • SPUTNIK V

India-Bangladesh sign MoU on COVID-19 Vaccine

On November 5, 2020, the Government of Bangladesh signed a Memorandum of Understanding with the Serum Institute of India for priority delivery of 3 crore COVID-19 vaccine doses. This COVISHIELD Vaccines was developed by AstraZeneca and University of Oxford. Highlights According to the agreement, initially 1.5 crore people will be vaccinated as each person requires ..

Month: Current Affairs - November, 2020

Category: International Current Affairs

Topics: Bharat Biotech • COVAX • COVAXIN • COVID-19 vaccine • Covishield • eVIN • GAVI • ICMR • India-Bangladesh • Serum Institute of India

Phase-2 trials of Bharat Biotech vaccine to begin in September

As reported by India Today, the phase I trial for the COVID 19 vaccine made by Bharat Biotech is complete and the Phase II of this trial is going to commence in September. In the first phase of the trial, the vaccine, known as Covaxin, is safe for human usage. Details of the Phase I ..

Month: Current Affairs - August, 2020

Category: India Nation & States Current Affairs

Topics: Bharat Biotech • COVID-19 • COVID-19 vaccine • Phase I Trial • Phase II Trial • Serum Institute of India

Dr. Dangs Lab to Partner with Bharat Biotech for Human Trials of Covaxin

The Delhi-based private laboratory, Dr Dangs Lab, has announced that they have been selected as the central laboratory for human clinical trials of Covaxin, which is touted as the first-ever indigenous vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology, Pune. The human clinical trial ..

Month: Current Affairs - July, 2020

Category: India Nation & States Current Affairs

Topics: Bharat Biotech • COVAXIN • Dr Dangs Lab • National Institute of Virology (NIV) • NIV